2017 - 2018
Nilofar Jafari, PharmD, MPH
Dr. Jafari earned her Doctor of Pharmacy degree in 2015 from Virginia Commonwealth University School of Pharmacy. Upon graduation, she completed a PGY1/PGY2 Health System Pharmacy Administration Residency with Allegheny General Hospital, part of the Allegheny Health Network, while completing a Master of Public Health and a Health Systems Leadership Management Certificate at the University of Pittsburgh.
Dr. Jafari was selected for the 2017-2018 ACCP/ASHP/VCU Congressional Healthcare Policy Fellow Program. She obtained placement in the office of Senator Chris Murphy (D-CT) and worked on a variety of legislative and healthcare policy issues including drug shortages, prescription drug pricing, the opioid epidemic, mental health, and healthcare reform.
In her current role, she serves as a Senior Health Consultant at Booz Allen Hamilton in their military health division.
2016 - 2017
Mary Abdelmalak, PharmD
Dr. Abdelmalak was a community pharmacist with Rite Aid in Cleveland, Ohio. A native of Egypt, she moved to the United States at age 12. Abdelmalak earned her bachelor’s degree in biology and philosophy from John Carroll University and her Pharm.D. degree from The Ohio State University College of Pharmacy. She also completed a PGY1 Community Care Pharmacy Practice Residency at Ohio State. Her areas of interest in health policy include the correlation between behavioral/mental health policy, economic/social legislation and health outcomes as well as preventive medicine policies, population health analysis and access determination.
Abdelmalak’s Congressional Healthcare Policy Fellow experiences, which began July of 2016, included a week with the Brookings Institution and three weeks at ACCP with Edwin Webb, associate executive director, and John McGlew, director of government affairs. Following three weeks with ASHP’s Office of Policy, Planning and Communications, under the mentorship of Joe Hill of the government affairs staff, Dr. Abdelmalak began her placement with the office of Senator Charles “Chuck” Grassley of Iowa, who sits on the Senate Finance; Budget; Judiciary; and Agriculture, Nutrition and Forestry.
2015 - 2016
Rita A. Habib, PharmD, MPH
Dr. Habib earned her Doctor of Pharmacy degree in 2013 from Rutgers University at the Ernest Mario School of Pharmacy. During this time she interned at Robert Wood Johnson University Hospital, developing an interest in health-system pharmacy. She was also involved in several policy and advocacy efforts on local, state, and federal levels and served as regional delegate for the American Pharmacists Association’s Academy of Student Pharmacists in addition to becoming president of the Phi Lambda Sigma chapter at Rutgers.
Upon graduation, she moved to Pittsburgh to pursue a PGY1/PGY2 Health System Pharmacy Administration residency with Allegheny General Hospital, part of the Allegheny Health Network. During this time she also completed a Masters of Public Health at the University of Pittsburgh. The residency program provided her with the opportunity develop leadership and pharmacy management skills in information technology, finance, business strategy, medication safety and clinical program development.
In September and October of 2015 she completed the association component of the fellowship with ASHP and ACCP. In November, she began her placement with the office of Senator Michael F. Bennet from Colorado, who sits on the Senate Finance; Health, Education, Labor, and Pensions; as well as Agriculture, Nutrition and Forestry Committees. During her time with Senator Bennet she worked on legislation that was included in the Senate Biomedical Innovation Package as well as priorities in the Senate Finance Committee Bipartisan Chronic Care Working Group. Dr. Habib is currently working on policy proposals that cover a range of issues including drug and device innovation safety, drug pricing, health information technology, Medicare and Medicaid care coordination and child welfare.
2014 - 2015
Tracy Rupp, PharmD, MPH
Dr. Rupp is a pharmacist and dietitian with more than 10 years of hospital and public health experience. She previously worked as a Clinical Pharmacist at Duke University Medical Center where she provided pharmacy and nutrition support services to adult oncology, surgery, and medicine patients. Prior to becoming a pharmacist, she worked as a Pediatric Dietitian/Nutritionist at both Duke University Medical Center and at a Women, Infants, and Children (WIC) nutrition program. As a hospital dietitian, she provided nutrition care to preterm infants in the neonatal intensive care unit and worked with the pediatric cystic fibrosis team to evaluate and treat nutritional issues related to CF. Her public policy and health care career began when she was a Community Health Educator with the Peace Corps in Nicaragua and continued in her work as a Health Education Specialist in South Dakota’s HIV Prevention Program. While a Peace Corps volunteer, she obtained a U.S. Agency for International Development (USAID) Small Project Assistance grant to develop and implement a children’s nutrition program in conjunction with community volunteers.
She holds both Doctor of Pharmacy and Master of Public Health degrees from the University of North Carolina at Chapel Hill. She completed a PGY1 pharmacy residency at WakeMed Health and Hospitals in Raleigh, N.C., and is a Board Certified Pharmacotherapy Specialist and Registered Dietitian.
In September 2014, Dr. Rupp was selected for the ACCP/ASHP/VCU Congressional Healthcare Policy Fellowship and obtained placement in the office of Senator Robert P. Casey, Jr. (D-PA). In this capacity, she drafted legislation that would provide for public and private insurance reimbursement for medical foods and worked with stakeholders to develop legislation that would help prevent dextromethorphan abuse. She also provided research and analysis on numerous health care issues, including: antibiotic resistance, opioid abuse, Medicare and Medicaid, maternal and child health, drug and device regulation, and health information technology.
Upon completion of the Fellowship, she joined the National Center for Health Research (NCHR) as a Senior Fellow and subsequently became the Director of Public Health Policy Initiatives. NCHR is a nonprofit, nonpartisan think tank focused on the application of evidence-based research to support new, more effective programs, policies, and medical treatments for children and adults. In this role, she translated medical research into compelling and persuasive information for federal and state legislators and policymakers. She is also a Patient Representative on the Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) and a member of the Public Policy Committee of the American Society for Parenteral and Enteral Nutrition (ASPEN). Currently Dr. Rupp is the Consumer Safety Officer in the Office of Compliance, U.S. Food & Drug Administration. She may be reached at firstname.lastname@example.org.
2013 - 2014
Daniel Nam R.Ph, J.D
Daniel worked as a pharmacist in Morgan Stanley Children's Hospital of New York until 2013. In 2008, he started a community pharmacy in a culturally diverse neighborhood. It was while operating the pharmacy that Daniel realized his passion for policy development, specifically around minority healthcare. As a result, he enrolled in law school, where he advocated for healthcare rights for seniors and indigent clients(New York Legal Assistance Group), externed at the NYS Attorney's General Office (Medicaid Fraud Unit, Hauppauge, NY), interned with the government affairs division in National Community Pharmacists Association (NCPA), and campaigned for a Congressional race. Daniel graduated law school in 2013 and started his Congressional Healthcare Policy Fellowship a short time later.
During the year-long Congressional Healthcare Policy Fellowship, Daniel worked in the personal office of U.S. Senator Michael F. Bennet. There, he staffed on legislative and policy issues, which heavily included staffing healthcare issues from the U.S. Senate H.E.L.P. and Finance Committees. He also worked heavily with Colorado state constituents on various healthcare and child welfare issues. During the fellowship, Daniel was able to gain valuable insight and experience regarding politics, policy-making, and effective legislating.
After the fellowship, Daniel joined the Defense and Intelligence Group of the government consulting firm, Booz Allen Hamilton. There, he worked on DoD healthcare contracts, including the MHS 90 Day Follow On and Operation Live Well contracts. As part of the Operation Live Well contract, he gained consulting and project management skills by leading the Analytics and the Congressional Report teams. Currently Dr. Nam is the Executive Director of Federal Programs for America's Health Insurance Plans. He can be reached at email@example.com and on Twitter @danieljnam
2012 - 2013
Derek Griffing, PharmD, MPH
Derek Griffing, PharmD, MPH, received his Master of Public Health degree from the Johns Hopkins Bloomberg School of Public Health and his Doctor of Pharmacy degree from the Chicago College of Pharmacy at Midwestern University. Derek was a pharmacist at Johns Hopkins Hospital prior to beginning the fellow program.
As the 2012-2013 ACCP/ASHP/VCU Congressional Healthcare Policy Fellow, Derek spent one month with the government affairs division at both ACCP and ASHP, and in November attained a position as a health policy fellow on Capitol Hill in the office of Senator Sheldon Whitehouse (Rhode Island).
Derek was responsible for staffing Senator Whitehouse at Senate Health, Education, Labor, and Pensions (HELP) Committee hearings and meetings. In this capacity, he led his office on compounding pharmacy legislation that was developed in response to the 2012 fungal meningitis outbreak. Derek managed stakeholder concerns, helped develop policies to protect public health, and participated in bipartisan negotiations. Derek also wrote speeches for Senator Whitehouse and was responsible for keeping the Senator up to speed on numerous health care delivery system reforms in the Affordable Care Act.
After completing the fellow program, Derek accepted a position as a Research Associate in the Center for Health Policy at the Brookings Institution in Washington, D.C. In this role he managed multiple projects related to improving regulatory science, evidence development, and innovation in medical products in the United States. Derek is currently a policy analyst in the Office of Generic Drug Policy at the United States Food and Drug Administration (FDA). In this position, he conducts research on a broad range of legal and regulatory issues, and is supporting FDA in the Agency’s efforts to renegotiate the Generic Drug User Fee Amendments of 2012 (GDUFA). He is also an adjunct professor at Georgetown University.
2011 - 2012
Sarah Steinhardt, PharmD
Dr. Steinhardt earned her Doctor of Pharmacy degree With Distinction in 2003 from the Purdue University College of Pharmacy in West Lafayette, Indiana.
While at Purdue, she completed her Pharm.D. project by performing a pharmacy compounding experiment in simulated microgravity conditions at NASA’s Johnson Space Center in Houston, Texas.
After graduation, she practiced retail pharmacy for over six years combined at Walmart in Kokomo and Walgreens in both Crawfordsville and Rensselaer, Indiana and enrolled in the Indiana University Robert H. McKinney School of Law where she obtained her Juris Doctor degree in 2009 with a Concentration in Health Law.
While in law school, she served as a Note Development Editor for the Indiana Health Law Review, was named to the Order of the Barristers in the Robert H. Stanton Intramural Moot Court Competition, and selected as an Associate Justice for the Moot Court Board.
She then completed a PGY2 pharmacy management residency at the University of Pittsburgh Medical Center and obtained a Master of Science in Pharmacy Administration. During her residency, she gained experience in pharmacy & clinical operations, hospital staffing, medication safety, and leadership, as well as obtaining a Mastery of Teaching certification.
In 2011, she was selected to be the ACCP/ASHP/VCU Congressional Health Care Policy Fellow. Initially, she worked within the government affairs divisions of ACCP and ASHP, then obtained placement in the United States Senate in the personal office of Senator Ron Wyden where she enjoyed working with the Senator and staff on a portfolio of drug crime and judiciary issues.
She is currently an Assistant Professor at the University of South Florida in Tampa where she teaches the Jurisprudence course and an elective on Drugs of Abuse, Addiction, & Law Enforcement. She was voted P3 Teacher of the Year for 2014-2015. Her email is firstname.lastname@example.org.
2010 - 2011
Joshua Paul Lorenz, PharmD
Dr. Lorenz earned his Doctor of Pharmacy and Master of Business Administration degrees at Butler University in Indianapolis, IN. Upon graduation, he was selected as a PGY1 Ambulatory Care Pharmacy Practice Resident at The Ohio State University College of Pharmacy. He worked on an interdisciplinary team to help manage chronic diseases for patients at the Columbus Neighborhood Health Center, a group of federally qualified health centers with a multicultural population.
As the fourth Congressional Healthcare Policy Fellow, Dr. Lorenz obtained placement in the U.S. Senate Committee for Health, Education, Labor, and Pensions under ranking member Senator Enzi. His work included involvement with multiple divisions within HHS, including the FDA, CMS, and the NIH. In addition to working during the beginning of implementation of the Affordable Care Act, Dr. Lorenz's legislative portfolio involved drug shortages (FDA Safety and Innovation Act), user fees for generic pharmaceutical manufacturers (GDUFA), and Medicare Part D updates. He also currently sits on the Ohio Pharmacist Association Legal and Regulatory Committee.
Dr. Lorenz is currently a clinical assistant professor at the James L. Winkle College of Pharmacy at the University of Cincinnati in Cincinnati, OH. Prior to his current position at the University of Cincinnati, Dr. Lorenz moved from Washington, DC, to Cincinnati, OH, after being hired as Assurex Health's first Medical Science Liaison. During his time at Assurex Health, he educated hundreds of physicians and nurse practitioners about genomics and pharmacogenomics and how to utilize genetic information in everyday clinical practice to improve the lives of patients. In addition to clinical pharmacogenomics, his areas of interest also include chronic disease management, digital health, and health outcomes. He can be reached at Joshua.Lorenz@uc.edu and on Twitter @CincyPharmD.
2008 - 2010
Stephanie Hammonds, PharmD
Dr. Hammonds earned her Doctor of Pharmacy degree in 2004 from Purdue University where she also pursued nuclear pharmacy certification and a French minor, created an experiential clerkship rotation at Lilly France (Eli Lilly and Company) in Suresnes, and focused her final project on the differences in pharmacy practice between France and the US. Upon graduation, she joined The Johns Hopkins Hospital in Baltimore, Maryland as a Point-of-Care Pharmacist, focused in pediatric oncology. Additionally, she co-founded the hospital’s Pediatric Pharmacy Safety Committee, and served on the compliance committee to update the hospital’s sterile compounding areas to the United States Pharmacopeial (USP) Convention’s chapter 797 standards.
In 2006, Stephanie moved to Brooklyn, New York to work in the New York Presbyterian – Weill Cornell Medical Center’s surgery pharmacy. She also served as the Interim Chair of the Legislative Action Committee for the New York City Society of the New York State Council of Health-System Pharmacists and volunteer tutored high school biology and chemistry. In September of 2007, she returned to her hometown, York, Pennsylvania, to assist her family to care for her grandmother, while working as a community pharmacist for Target and pursuing graduate coursework in health policy.
n 2008, Stephanie was selected as the ASHP / ACCP / VCU Congressional Health Policy Fellow and obtained placement in the U.S. Senate Committee on Health, Education, Labor, and Pensions (HELP) Majority Health policy office, chaired by Senators Kennedy and Harkin (after Senator Kennedy’s death). Her work focused on antimicrobial resistance, global health, and health quality and delivery system improvement initiatives for the national health reform debate. Although she contributed to other sections, she wrote section 3503 of the Patient Protection and Affordable Care Act (P.L. 111-148), Medication Management in the Treatment of Chronic Diseases.
In 2010, she joined the U.S. Department of Health and Human Services’ (DHHS) Health Resources and Services Administration (HRSA) in the Office of Pharmacy Affairs (OPA), where her work focused on the 340B Drug Pricing Program, the Patient Safety and Clinical Pharmacy Services Collaborative (PSPC), and Affordable Care Act (ACA) provisions related to the patient centered medical home, care coordination during transitions of care, and clinical pharmacy services. After the office restructured in 2011, Stephanie’s returned to Baltimore where her work blended policy and practice to manage the successful launch of two new outpatient hospital pharmacies at LifeBridge Health. Concurrently, she was appointed by Governor Martin O'Malley to one of two health-system pharmacy seats on the Maryland Board of Pharmacy.
Stephanie moved in 2012 to the DHHS’ Centers for Medicare and Medicaid Services (CMS) where her work focuses on policy for the Medicare Prescription Drug Benefit (Part D). She has particular interest in the comparative economics and policy of global pharmaceutical care services delivery and in her spare time, enjoys cooking, dancing, triathlons, and travelling. She can be reached at Stephanie.M.Hammonds.PharmD@gmail.com
2007 - 2008
Anna Legreid Dopp, PharmD
Anna Legreid Dopp, PharmD completed her Doctor of Pharmacy degree in 2002 from the University of Minnesota College of Pharmacy. Upon graduation she began working at Medtronic, Inc. as a manager and Principal Training and Education Specialist in the Cardiac Rhythm Disease Management Core Clinical and Outcomes Research department.
In May 2005 she accepted a position as a Clinical Assistant Professor at the University of Wisconsin School of Pharmacy in the Extension Services in Pharmacy Division. Three years later, she took a leave of absence from the University of Wisconsin and completed a Congressional Health Care Policy Fellow Program in Washington, DC where she worked on health and social legislation in the office of Senator Joe Lieberman.
She has worked as a clinical pharmacist and as a medication use policy analyst at the University of Wisconsin Hospitals and Clinics as well as the Vice President of Public Affairs for the Pharmacy Society of Wisconsin and serves as the Editor of the Journal of the Pharmacy Society of Wisconsin. Recently Dr. Dopp joined the American Society of Health-System Pharmacists (ASHP) as the Director of Clinical Guidelines and Quality Improvement.
2006 - 2007
George Neyarapally, PharmD, MPH
Dr. Neyarapally received his B.S. in Finance, magna cum laude, honors scholar, from the University of Connecticut, M.P.H. from the Johns Hopkins Bloomberg School of Public Health and Pharm.D. from the University of North Carolina. After graduating from pharmacy school, he worked as a pharmacist for PPD Medical Communications in North Carolina.
George was the Inaugural 2006 – 2007 VCU-ACCP-ASHP Pharmacy Healthcare Policy Fellow. As a Fellow, Dr. Neyarapally worked in the Office of the Assistant Secretary for Preparedness and Response (ASPR) in the Office of the Secretary, U.S. Department of Health and Human Services; in a personal U.S. Congressional office, and in the government affairs offices of the American Society of Health-Systems Pharmacists (ASHP) and the American College of Clinical Pharmacy (ACCP). As a Congressional Health Fellow, Dr. Neyarapally advised on a comprehensive FDA bill, S.1082, the FDA Revitalization Act of 2007, along with several other domestic and global health policy issues.
After completing the fellowship, from 2007 to 2008, George worked in the Center for Outcomes and Evidence at the Agency for Healthcare Research and Quality (AHRQ) on a variety of national comparative effectiveness research initiatives. From 2008 to 2014, George started working at the FDA and contributed to multiple FDA initiatives. Dr. Neyarapally chaired a FDA guidance working group and published FDA articles on public health and policy issues. George served as a member of review teams for new drugs and biologics and presented at internal and external seminars and conferences. In 2011, he completed a detail as a Senior Policy Analyst in FDA’s Office of Compliance, where he worked on FDA compliance-related policy issues.
From 2014 to 2015, Dr. Neyarapally worked as Pharmacy Director in the State of New Hampshire and continued on as an evening health law student and Leadership Scholar at the University of Maryland School of Law. As Director, he contributed to the development of pharmaceutical policies, collaborated with stakeholder groups and managed care organizations to optimize population health management, and developed quality and safety improvement initiatives and metrics. As a health law student, he has presented, researched, and published on national health and pharmaceutical policy and law issues, worked as an extern at the National Public Health Law Network, and participated in the 2012 Inaugural Health Law Compliance and Regulatory Competition.